Patent Assignment
Reel/Frame 025493/0384
Security Agreement
Recorded: 2010-12-13
Pages: 10
Assignors
PACIRA PHARMACEUTICALS, INC. (A CALIFORNIA CORPORATION)
Executed: 2010-11-24
PACIRA PHARMACEUTICALS, INC. (A DELAWARE CORPORATION)
Executed: 2010-11-24
Assignees
HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
400 HAMILTON AVENUE, SUITE 301, PALO ALTO, CALIFORNIA, 94301
HERCULES TECHNOLOGY III, L.P.
400 HAMILTON AVENUE, SUITE 301, PALO ALTO, CALIFORNIA, 94301
Covered Properties
(28)
Method for Treating Neurological Disorders
Patent:
5,455,044 →
Application:
08/062,799 →
Heterovesicular Liposomes
Patent:
5,422,120 →
Application:
08/078,701 →
Preparation of Multivesicular Liposomes for Controlled Release of Encapsulated Biologically Active Substances
Patent:
5,993,850 →
Application:
08/305,158 →
Heterovesicular Liposomes
Patent:
5,576,017 →
Application:
08/393,724 →
Multivesicular Liposomes Having a Biologically Active Substance Encapsulated Therein in the Presence of a Hydrochloride
Patent:
5,723,147 →
Application:
08/472,126 →
Multivesicular Lipsomes Having a Biologically Active Substance Encapsulated Therein in the Presence of a Hydrochloride
Patent:
5,807,572 →
Application:
08/473,019 →
Method for Treating Neurological Disorders
Patent:
5,576,018 →
Application:
08/484,501 →
Epidural Administration of Therapeutic Compounds with Sustained Rate of Release
Patent:
5,931,809 →
Application:
08/502,569 →
Cyclodextrin Liposomes Encapsulating Pharmacologic Compounds and Methods for Their Use
Patent:
5,759,573 →
Application:
08/535,256 →
Method for Producing Liposomes with Increased Percent of Compound Encapsulated
Patent:
5,997,899 →
Application:
08/723,583 →
Method for Utilizing Neutral Lipids to Modify in Vivo Release from Multivesicular Liposomes
Patent:
5,891,467 →
Application:
08/792,566 →
Multivescular Liposomes with Controlled Release of Encapsulated Biologically Active Substances
Patent:
5,766,627 →
Application:
08/862,589 →
High and Low Load Formulations of Igf-I in Multivesicular Liposomes
Patent:
6,306,432 →
Application:
08/925,531 →
Modulation of Drug Loading in Multivescular Liposomes
Patent:
6,106,858 →
Application:
08/925,532 →
Epidural Administration of Therapeutic Compounds with Sustained Rate of Release
Multivesicular Liposomes Utilizing Neutral Lipids to Modify in Vivo Release
Patent:
5,962,016 →
Application:
08/974,296 →
Multivesicular Liposomes with Controlled Release of Encapsulated Biologically Active Substances
Patent:
6,132,766 →
Application:
09/045,236 →
Sustained-Release Liposomal Anesthetic Compositions
Patent:
6,045,824 →
Application:
09/156,214 →
Biodegradable Compositions for the Controlled Release of Encapsulated Substances
Patent:
6,277,413 →
Application:
09/356,218 →
Method for Producing Liposomes with Increased Percent of Compound Encapsulated
Patent:
6,193,998 →
Application:
09/431,523 →
Method for Producing Liposomes with Increased Percent of Compound Encapsulated
Patent:
6,171,613 →
Application:
09/431,525 →
Method for Producing Liposomes with Increased Percent of Compound Encapsulated
Patent:
6,241,999 →
Application:
09/454,521 →
Biodegradable Compositions for the Controlled Release of Encapsulated Substances
Encapsulation of nanosuspensions in liposomes and microspheres
Application:
10/161,969 →
Publication:
US 2003/0096000
Sustained-Release Liposomal Anesthetic Compositions
Production of Multivesicular Liposomes
Hyaluronidase as an Adjuvant for Increasing the Injection Volume and Dispersion of Large Diameter Synthetic Membrane Vesicles Containing a Therapeutic Agent
Application:
12/790,587 →
Publication:
US 2010/0305500
Sustained Release Formulation of Methotrexate as a Disease-Modifying Antirheumatic Drug (Dmard) and an Anti-Cancer Agent
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 10, 2007
From: JAGOTEC AG
To: SKYEPHARMA INC.
Reel/Frame 019795/0944 →
Change of Name
Dec 7, 2007
From: SKYEPHARMA INC.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 020206/0992 →
Change of Name
Feb 21, 2008
From: SKYEPHARMA, INC.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 020550/0289 →
Security Agreement
May 4, 2010
From: PACIRA PHARMACEUTICALS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 024329/0340 →
Change of Name
Dec 3, 2010
From: CHIRON CORPORATION
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 025451/0758 →
Release of Security Interest
Dec 13, 2010
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 025475/0977 →
Release of Security Interest
May 4, 2012
From: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.; HERCULES TECHNOLOGY III, L.P.
To: PACIRA PHARMACEUTICALS, INC., A CALIFORNIA CORPORATION; PACIRA PHARMACEUTICALS, INC., A DELAWARE CORPORATION
Reel/Frame 028156/0580 →